Annual Cash & Cash Equivalents
$20.73 M
+$9.86 M+90.76%
December 31, 2023
Summary
- As of February 7, 2025, VNRX annual cash & cash equivalents is $20.73 million, with the most recent change of +$9.86 million (+90.76%) on December 31, 2023.
- During the last 3 years, VNRX annual cash & cash equivalents has risen by +$1.29 million (+6.61%).
- VNRX annual cash & cash equivalents is now -4.38% below its all-time high of $21.68 million, reached on December 31, 2016.
Performance
VNRX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$5.41 M
-$584.80 K-9.75%
September 30, 2024
Summary
- As of February 7, 2025, VNRX quarterly cash and cash equivalents is $5.41 million, with the most recent change of -$584.80 thousand (-9.75%) on September 30, 2024.
- Over the past year, VNRX quarterly cash and cash equivalents has dropped by -$15.32 million (-73.88%).
- VNRX quarterly cash and cash equivalents is now -83.62% below its all-time high of $33.06 million, reached on March 31, 2021.
Performance
VNRX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
VNRX Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +90.8% | -73.9% |
| 3 y3 years | +6.6% | -76.4% |
| 5 y5 years | +54.4% | -74.1% |
VNRX Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +90.8% | -77.2% | at low |
| 5 y | 5-year | at high | +90.8% | -83.6% | at low |
| alltime | all time | -4.4% | >+9999.0% | -83.6% | -100.0% |
VolitionRx Limited Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.41 M(-9.7%) |
| Jun 2024 | - | $6.00 M(-49.0%) |
| Mar 2024 | - | $11.77 M(-43.2%) |
| Dec 2023 | $20.73 M(+90.8%) | $20.73 M(+91.8%) |
| Sep 2023 | - | $10.81 M(-45.3%) |
| Jun 2023 | - | $19.74 M(+97.2%) |
| Mar 2023 | - | $10.01 M(-7.9%) |
| Dec 2022 | $10.87 M(-47.2%) | $10.87 M(-33.8%) |
| Sep 2022 | - | $16.42 M(-1.9%) |
| Jun 2022 | - | $16.73 M(-29.5%) |
| Mar 2022 | - | $23.73 M(+15.3%) |
| Dec 2021 | $20.58 M(+5.8%) | $20.58 M(-10.1%) |
| Sep 2021 | - | $22.90 M(-18.0%) |
| Jun 2021 | - | $27.91 M(-15.6%) |
| Mar 2021 | - | $33.06 M(+70.0%) |
| Dec 2020 | $19.44 M(+14.6%) | $19.44 M(-7.1%) |
| Sep 2020 | - | $20.93 M(-1.8%) |
| Jun 2020 | - | $21.31 M(+78.0%) |
| Mar 2020 | - | $11.97 M(-29.4%) |
| Dec 2019 | $16.97 M(+26.4%) | $16.97 M(-13.9%) |
| Sep 2019 | - | $19.70 M(+6.4%) |
| Jun 2019 | - | $18.51 M(+14.5%) |
| Mar 2019 | - | $16.17 M(+20.4%) |
| Dec 2018 | $13.43 M(+32.7%) | $13.43 M(-18.0%) |
| Sep 2018 | - | $16.37 M(+37.7%) |
| Jun 2018 | - | $11.89 M(-16.6%) |
| Mar 2018 | - | $14.26 M(+41.0%) |
| Dec 2017 | $10.12 M(-53.3%) | $10.12 M(-26.9%) |
| Sep 2017 | - | $13.84 M(-16.1%) |
| Jun 2017 | - | $16.51 M(-10.7%) |
| Mar 2017 | - | $18.47 M(-14.8%) |
| Dec 2016 | $21.68 M(+266.4%) | $21.68 M(+73.0%) |
| Sep 2016 | - | $12.53 M(-13.6%) |
| Jun 2016 | - | $14.50 M(-14.7%) |
| Mar 2016 | - | $17.01 M(+187.5%) |
| Dec 2015 | $5.92 M(+176.6%) | $5.92 M(-13.7%) |
| Sep 2015 | - | $6.85 M(-26.4%) |
| Jun 2015 | - | $9.31 M(-15.6%) |
| Mar 2015 | - | $11.03 M(+415.7%) |
| Dec 2014 | $2.14 M | $2.14 M(-11.6%) |
| Sep 2014 | - | $2.42 M(+33.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2014 | - | $1.81 M(-35.4%) |
| Mar 2014 | - | $2.80 M(+215.2%) |
| Dec 2013 | $888.70 K(+136.1%) | $888.70 K(+87.7%) |
| Sep 2013 | - | $473.50 K(-36.9%) |
| Jun 2013 | - | $750.70 K(+82.7%) |
| Mar 2013 | - | $410.90 K(+9.2%) |
| Dec 2012 | $376.40 K(+8.2%) | $376.40 K(+19.4%) |
| Sep 2012 | - | $315.30 K(-18.4%) |
| Jun 2012 | - | $386.20 K(+77.3%) |
| Mar 2012 | - | $217.80 K(>+9900.0%) |
| Dec 2011 | $347.90 K(>+9900.0%) | - |
| Aug 2011 | - | $100.00(-90.9%) |
| Aug 2011 | $100.00(-80.0%) | - |
| May 2011 | - | $1100.00(-45.0%) |
| Feb 2011 | - | $2000.00(+185.7%) |
| Nov 2010 | - | $700.00(+40.0%) |
| Aug 2010 | $500.00(-85.3%) | $500.00(+400.0%) |
| May 2010 | - | $100.00(-85.7%) |
| Feb 2010 | - | $700.00(-12.5%) |
| Nov 2009 | - | $800.00(-76.5%) |
| Aug 2009 | $3400.00(+3.0%) | $3400.00(+9.7%) |
| May 2009 | - | $3100.00(+181.8%) |
| Feb 2009 | - | $1100.00(+37.5%) |
| Nov 2008 | - | $800.00(-75.8%) |
| Aug 2008 | $3300.00(-23.3%) | $3300.00(+83.3%) |
| May 2008 | - | $1800.00(-28.0%) |
| Feb 2008 | - | $2500.00(+38.9%) |
| Nov 2007 | - | $1800.00(-58.1%) |
| Aug 2007 | $4300.00(+87.0%) | $4300.00(+616.7%) |
| May 2007 | - | $600.00(-53.8%) |
| Feb 2007 | - | $1300.00(+333.3%) |
| Nov 2006 | - | $300.00(-87.0%) |
| Aug 2006 | $2300.00(+2200.0%) | $2300.00(-47.7%) |
| May 2006 | - | $4400.00(-48.8%) |
| Feb 2006 | - | $8600.00(-22.5%) |
| Nov 2005 | - | $11.10 K(>+9900.0%) |
| Aug 2005 | $100.00(0.0%) | $100.00(>+9900.0%) |
| May 2005 | - | $0.00(-100.0%) |
| Feb 2005 | - | $100.00(0.0%) |
| Nov 2004 | - | $100.00 |
| Aug 2004 | $100.00 | - |
FAQ
- What is VolitionRx Limited annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for VolitionRx Limited?
- What is VolitionRx Limited annual cash & cash equivalents year-on-year change?
- What is VolitionRx Limited quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for VolitionRx Limited?
- What is VolitionRx Limited quarterly cash and cash equivalents year-on-year change?
What is VolitionRx Limited annual cash & cash equivalents?
The current annual cash & cash equivalents of VNRX is $20.73 M
What is the all time high annual cash & cash equivalents for VolitionRx Limited?
VolitionRx Limited all-time high annual cash & cash equivalents is $21.68 M
What is VolitionRx Limited annual cash & cash equivalents year-on-year change?
Over the past year, VNRX annual cash & cash equivalents has changed by +$9.86 M (+90.76%)
What is VolitionRx Limited quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of VNRX is $5.41 M
What is the all time high quarterly cash and cash equivalents for VolitionRx Limited?
VolitionRx Limited all-time high quarterly cash and cash equivalents is $33.06 M
What is VolitionRx Limited quarterly cash and cash equivalents year-on-year change?
Over the past year, VNRX quarterly cash and cash equivalents has changed by -$15.32 M (-73.88%)